Catheter Precision (FRA:4RM) ROCE % : -38.87% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Catheter Precision ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Catheter Precision's annualized ROCE % for the quarter that ended in Mar. 2024 was -38.87%.

Catheter Precision ROCE % Historical Data

The historical data trend for Catheter Precision's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision ROCE % Chart

Catheter Precision Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-109.27

-106.50

-148.17

-190.42

-90.94

Catheter Precision Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-155.74	-14.96	-34.21	-34.75	-38.87

Catheter Precision ROCE % Calculation

Catheter Precision's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-15.759	/	( ( (15.893 - 7.152)	+	(28.185 - 2.267) )	/ 2 )
	=	-15.759	/	( (8.741	+	25.918)	/ 2 )
	=	-15.759	/	17.3295
	=	-90.94 %

Catheter Precision's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-9.628	/	( ( (28.185 - 2.267)	+	(25.779 - 2.162) )	/ 2 )
	=	-9.628	/	( ( 25.918	+	23.617 )	/ 2 )
	=	-9.628	/	24.7675
	=	-38.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Catheter Precision (FRA:4RM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Catheter Precision ROCE % Related Terms

Thank you for viewing the detailed overview of Catheter Precision's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Catheter Precision (FRA:4RM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (FRA:4RM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VTAK:USA

Address

1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708

Website

https://www.ramed.com

Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.

Catheter Precision (FRA:4RM) Headlines

No Headlines